Objective: To measure the correlation of plasma adenosine levels with plate
let activation in women with preeclampsia.
Methods: Plasma adenosine concentration and expression of P-selectin, a mar
ker for platelet activation, were measured in 18 normal pregnant women and
18 preeclamptic women. The effect of 8-sulfophenyltheophylline, an adenosin
e receptor blocker, on expression of P-selectin on platelets also was measu
red.
Results: Plasma adenosine level averaged 0.77 +/- 0.11 muM (standard error
of the mean [SEM]) in women with preeclampsia, significantly higher than th
e mean level of 0.47 +/- 0.08 muM in women with normal pregnancies (P < .05
). Expression of P-selectin on platelets averaged 7.8 +/- 1.2% in women wit
h preeclampsia, also significantly higher than the mean level of 4.7 +/- 0.
7% in normal pregnancy (P < .05). Adenosine receptor blockade significantly
increased expression of P-selectin on platelets in women with preeclampsia
by 26% (P < .05), which was significantly higher than the 13% increase of
activation in those with normal pregnancies (P < .05).
Conclusion: Adenosine is an established platelet activation suppressor. Inc
reased plasma levels of adenosine in preeclampsia might partially compensat
e and tend to prevent further excessive platelet activation in women with p
reeclampsia. (C)2001 by The American College of Obstetricians and Gynecolog
ists.